Back

The current and future total health care costs of atrial fibrillation

25 August 2023 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Prognosis and outcome in patients with atrial fibrillation Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Roopinder Sandhu

University of Calgary, Calgary (Canada)

7 More presentations in this session

Presentation thumbnail
Cigarette smoking and structural brain deficits in patients with atrial fibrillation
Mr R. Peter (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: ASPIRE (efficacy and safety of apixaban in real-world practice in Korean frail patients with AF)
Miss J. Choi (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Association of atrial fibrillation burden with rhythm control and stroke prevention interventions among patients with cardiac implantable electronic devices
Doctor G. Peigh (Chicago, US)
Abstract Slides Video
Presentation thumbnail
Risk differences between atrial fibrillation patients with different clinical phenotypes: insights from the French population
Doctor A. Fawzy (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Pulmonary hypertension is an adverse risk factor for peri-procedural complications in patients undergoing cardioversion for atrial fibrillation
Doctor M. Kodali (Milwaukee, US)
Abstract Slides

Access the full session

Session thumbnail
Prognosis and outcome in patients with atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Incidence, management and outcomes of patients with incident atrial fibrillation in the contemporary direct oral anti coagulants era. A national study
thumbnail
Congress Presentation
Cost-effectiveness of apixaban vs aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial
thumbnail
Congress Session
Registries on atrial fibrillation and sudden death

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources